glp 1 for osa Sleep Apnea May Amplify GLP-1 Survival Benefits in Type 2 Diabetes GLP-1s Likely New Frontier in

However, these two natural GLP-1R agonists are rapidly digested by the enzyme DPP-4 and cleared by the kidneys within 1-2 minutes, making them unsuitable for direct therapeutic use

Olfactory dysfunction, including parosmia, has been associated with liraglutide use 46 , likely reflecting GLP-1R-mediated modulation of odor-evoked insulin secretion and foraging behaviors in the olfactory bulb 51,52

Indeed, in the cardiovascular outcome trial (CVOT) for semaglutide, SUSTAIN 6 a relatively short (two-year) and small (3,297 individuals) preregistration trial (an extensive CVOT in obese individuals without T2DM (SELECT) is expected to complete in 2024) HbA 1c was powerfully and durably reduced

liraglutide: 1.2 mg/day (LIRA: n = 11)

S3a, b)